Composition comprising a culture solution of mesenchymal stem cells for the treatment of neural diseases
US10238692B2 · kind B2 · utility
3Cited by
4References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 16, 2009 |
| Grant date | Mar 26, 2019 |
| Priority date | — |
| Expiry date | Nov 16, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2502/137
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are a pharmaceutical composition for prevention and treatment of a neural disease including at least one selected from the group consisting of mesenchymal stem cells (MSCs), a culture solution of the MSCs, activin A, PF4, decorin, galectin 3, GDF15, glypican 3, MFRP, ICAM5, IGFBP7, PDGF-AA, SPARCL1, thrombospondin-1, WISP1, progranulin, IL-4, a factor inducing expression thereof, and any combination thereof, and a method therefor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.